Shares of Novavax Inc. NVAX slid 3.09% to $7.83 Wednesday, on what proved to be an all-around mixed trading session for the ...
Novavax Inc. closed 66.14% below its 52-week high of $23.86, which the company reached on June 6th.
Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Novavax (NVAX – Research Report) today and set a price target of ...
Stocks saw a massive turnaround during Monday’s volatile trading session on news of the pausing of U.S. tariffs against ...
Bullish option flow detected in Novavax (NVAX) with 5,702 calls trading, 1.1x expected, and implied vol increasing almost 10 points to 99.21%. 1/31 weekly 10 calls and 1/31 weekly 9.5 calls are ...
Therefore, knowing a company's potential revenue growth is crucial. For Novavax, the consensus sales estimate for the current quarter of $90.72 million indicates a year-over-year change of -68.9%.
which Novavax falls in, has gained 0.7%. The key question now is: What could be the stock's future direction? Although media reports or rumors about a significant change in a company's business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results